logo

MongoDB Expands Availability of MongoDB Atlas in Southeast Asia to Support Accelerated Regional Growth

Zawya25-03-2025

MongoDB Atlas now available on AWS Regions in Malaysia and Thailand // Local availability empowers businesses across the region—including Botnoi and EasyEat—to innovate and improve user experiences
SINGAPORE - Media OutReach Newswire - 25 March 2025 - MongoDB, the leading database for modern applications, today announced that its industry-leading, multi-cloud data platform, MongoDB Atlas, is now available on Amazon Web Services (AWS) Regions in Malaysia and Thailand. This expansion comes on the heels of significant growth in the Southeast Asia region with headcount growing over 200% in the last two years and the region becoming a key part of MongoDB's Asia Pacific business, which has reached more than $220 million USD in annual revenue.
Already available across cloud regions in Australia, Hong Kong, India, Indonesia, Japan, Singapore, and South Korea, MongoDB Atlas is fueling MongoDB's growth across Southeast Asia. MongoDB Atlas provides tens of thousands of customers around the world the performance, resilience, security, and flexibility to build their modern applications. With MongoDB Atlas on AWS, Malaysian and Thai customers in the financial services, telecommunications, healthcare, agritech, and manufacturing sectors—such as Botnoi and EasyEat—can now enjoy ultra-high availability, data sovereignty, and lower latency.
'Bringing MongoDB Atlas to Malaysia and Thailand on AWS is a big milestone for us, and is an important step in MongoDB's growth across the region,' said Stewart Garrett, Regional Vice President, ASEAN and Japan, MongoDB. 'We're giving businesses the tools to tap into real-time insights, strong security, and unmatched scalability so they can roll out modern applications faster. This launch goes beyond improved availability and latency—it supports digital transformation, sparking innovation and boosting economic growth across Southeast Asia.'
"AWS is committed to helping customers innovate with the best tools and technologies where they need them most,' said Kirsten Gilbertson, Partner Organization Leader, ASEAN, AWS. 'We're excited to support MongoDB Atlas's expansion into Malaysia and Thailand, bringing powerful database capabilities closer to customers on our regional infrastructure. This collaboration helps businesses across Southeast Asia innovate faster while meeting their data residency requirements and performance needs."
Customers welcome MongoDB Atlas regional expansion
MongoDB customers across Southeast Asia are seeing rapid innovation and growth with MongoDB Atlas.
Thailand's Botnoi is using MongoDB Atlas to efficiently manage and analyze large datasets, which is essential for providing AI applications like chatbots and voice bots to automate customer service and technical support. 'MongoDB Atlas on AWS helps us manage and analyze huge volumes of data easily, allowing us to rapidly innovate to deliver improved customer service solutions for our clients,' said Dr. Piyoros Tungthamthiti, Chief Technology Officer and Co-Founder of Botnoi. 'We are thrilled that MongoDB is expanding Atlas to our country, allowing us to benefit from the scalability and agility of the cloud infrastructure right here in Bangkok.'
Malaysia's EasyEat delivers a software-as-a-service point-of-sale system to restaurants. With MongoDB Atlas, the company simplifies daily operations, optimizes costs, and enhances customer satisfaction for more than 2,000 restaurants and over four million consumers across Malaysia and Indonesia. 'Our customers depend on us to manage their data to improve the customer experience. With MongoDB Atlas now hosted locally in Malaysia, we can accelerate our innovation efforts,' said Abdul Khalid, Co-Founder & CTO, EasyEat. 'We expect that with MongoDB we will further simplify our operations, costs, and user satisfaction while keeping our data in-country.'
Hashtag: #MongoDB
https://www.mongodb.com/
https://www.linkedin.com/company/mongodbinc/
The issuer is solely responsible for the content of this announcement.
About MongoDB
Headquartered in New York, MongoDB's mission is to empower innovators to create, transform, and disrupt industries with software and data. MongoDB's unified, intelligent data platform was built to power the next generation of applications, and MongoDB is the most widely available, globally distributed database on the market. With integrated capabilities for operational data, search, real-time analytics, and AI-powered retrieval, MongoDB helps organizations everywhere move faster, innovate more efficiently, and simplify complex architectures. Millions of developers and more than 50,000 customers across almost every industry—including 70% of the Fortune 100—rely on MongoDB for their most important applications. To learn more, visit mongodb.com.
MongoDB

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Central Pattana & Partners Invest THB 1B in ‘Summer Grand Sale 2025' to Boost Tourism and Thailand's Shopping Appeal
Central Pattana & Partners Invest THB 1B in ‘Summer Grand Sale 2025' to Boost Tourism and Thailand's Shopping Appeal

Web Release

time19 hours ago

  • Web Release

Central Pattana & Partners Invest THB 1B in ‘Summer Grand Sale 2025' to Boost Tourism and Thailand's Shopping Appeal

Central Pattana plc, Thailand's leading real estate developer and operator of Central shopping centers nationwide, is teaming up with affiliates under Central Group and key partners across both public and private sectors to launch the Summer Grand Sale 2025—the biggest mid-year sale shopping event of the year. With an investment of THB 1 billion, the campaign offers discounts of up to 80% from over 28,000 brands and 12,000 stores across Central shopping centers. It targets a global audience, including short-haul, long-haul, and high-spending international shoppers. The event will run from 30 May to 13 July 2025 at premier locations including centralwOrld, Central Village Outlet, Central Pattaya, Central Marina Outlet, Central Samui, and Central Phuket. This landmark campaign is backed by Thailand's largest retail alliance, including Central Retail, Central Pattana shopping centers, Central Department Store, Robinson Department Store, Central Online (Central App), Supersports, Central Marketing Group (CMG), Tops Food Hall, Tops, Tops Care, GO Wholesale, Power Buy, OfficeMate, B2S, Robinson Lifestyle, Central Restaurants Group, Centara Hotels and Resorts, GO Hotel, Jubilee Diamond, Evolt Technology, Major Cineplex, SF Cinema, and The 1. It is also supported by the Tourism Authority of Thailand and other strategic partners. Central Pattana continues to collaborate closely with the Tourism Authority of Thailand under the Amazing Thailand Grand Sale campaign to establish Thailand as a premier global shopping destination. This campaign aims to highlight Thailand as a destination rich in food, culture, and shopping experiences. The campaign strategically targets quality tourists, including travelers from Middle East, China, Singapore, Hong Kong, Taiwan, and Malaysia, as well as long-haul visitors from Russia, Europe, the US, and Central Asia. Insights reveal diverse shopper preferences: Chinese tourists often seek Thai fashion and popular eateries; Hong Kong and Singaporean travelers gravitate toward craft goods and Thai desserts; Europeans and Americans favor international fashion brands and premium restaurants, while Middle Eastern and Russian tourists are especially drawn to luxury goods. Central Pattana continues to attract high-spending tourists— 'Quality Shoppers'—as demonstrated by growing e-wallet spending in key tourist malls such as Central Phuket, Central Chiangmai, Central Pattaya, and centralwOrld. This sustained growth reflects the success of its strategic efforts to drive premium tourism. Exclusive Offers for International Visitors: During Summer Grand Sale 2025, international tourists can enjoy exclusive promotions by signing up for The 1 Tourist membership. Members receive a free Tourist Welcome Package with discounts of up to 40%* at participating brands across all Central shopping centers in Thailand. Shoppers who spend THB 6,000* (or THB 5,000* for Klook customers) will receive a complimentary Good Goods Tote Bag valued at THB 690. Offers are available from 30 May to 13 July 2025 at the participating Central locations listed above.

Loyyal Expands Maharaja Club with Global Shopping Rewards
Loyyal Expands Maharaja Club with Global Shopping Rewards

Arabian Post

time20 hours ago

  • Arabian Post

Loyyal Expands Maharaja Club with Global Shopping Rewards

Air India has partnered with blockchain-based loyalty specialist Loyyal to allow Maharaja Club members to earn points on everyday purchases across key brands in the United States and the United Kingdom. The collaboration enables members to accrue Maharaja Points on shopping at major retailers such as Walmart, Victoria's Secret, New Balance, GAP, Victorinox and Alamo – marking a significant expansion of the airline's loyalty programme. Members now earn up to 99 Maharaja Points per USD 100 spent at Walmart, 310 points per GBP 100 at Victoria's Secret, 300 points at Victorinox, 45 at New Balance, 180 at GAP and 64 points at Alamo. These offerings are accessible via the Maharaja Club Partner Offers page on Air India's website, where members can select a brand and follow on-screen prompts to initiate their purchases. Shailesh Kumar Singh, Head of Loyalty at Air India, commented that the alliance with Loyyal 'makes it easier for our members to earn Maharaja Points on everyday essentials and shopping, without needing to fly frequently'. Meanwhile, Loyyal CEO Ashish Kumar Singh noted that the initiative 'significantly boosts the earning potential for Maharaja Club's members,' adding that it enriches daily experiences and complements travel benefits. ADVERTISEMENT The partnership follows a broader revamp of the Maharaja Club, which adopted a simplified tier structure, updated identity and enhanced customer features. Air India has added more than 50 non-airline partners over the last 18 months, supporting its transformation under the strategy and leveraging its Star Alliance membership. The move aligns with global loyalty trends, where airlines increasingly engage shoppers via retail partnerships. By enabling points accrual through non-travel spend, loyalty programmes become more relevant to everyday consumer behaviour, fostering engagement beyond flight activity. Consumers, meanwhile, gain tangible value even during non-travel periods. Maharaja Club's integration with Star Alliance further enhances its value proposition. As noted by Air India's own commentary, elite-tier members benefit from worldwide priority check-in, lounge access at over 1,100 locations, extra baggage allowance, and the ability to accrue and redeem points across the alliance's 25 carriers. These features remain central to the programme's repositioning. Industry analysts highlight that Loyyal's blockchain-based platform offers secure, transparent point tracking and easier integration of diverse partners. Though Air India and Loyyal have not disclosed technical details publicly, Loyyal's existing reputation in travel loyalty schemes supports confidence in seamless implementation. Under the agreement, Air India continues to broaden access to Maharaja Points across shopping categories. The move targets customers traveling abroad or residing outside India, reinforcing Air India's global outreach following its Tata Group-led transformation. In support, the programme emphasises that points can be redeemed for award flights and cabin upgrades through Air India or Star Alliance partners. The timing of the launch coincides with Air India's widened network with new interline agreements and route expansions, such as recent pacts with airlines like airBaltic, Cyprus Airways and Uzbekistan Airways, aimed at increasing global connectivity. As passengers gain more travel options, the value of earning and using loyalty points is projected to grow. As more household and lifestyle brands are added to the programme, members could diversify their point accrual even further. Air India has indicated that additional partners will be announced in due course, though specifics have not yet been released. Maharaja Club members benefit from streamlined user experience with clearly stated earning rates for each participating brand. For example, spending at Victoria's Secret yields 310 points per GBP 100, while spending at Victorinox delivers 300 points per USD 100 – figures that are prominently showcased on the shopping portal. Air India's alignment with Loyyal fits within its hospitality-driven repositioning under along with fleet modernisation, training investments, new routes, and enhanced premium services. The airline aims to appeal to international leisure and business travellers – particularly those based abroad – by offering points that can accrue through both travel and lifestyle spending. Industry commentators suggest that Loyyal's blockchain solution offers underlying benefits including transparent audit trails, fraud reduction and easy tracking of reward accrual from non-travel sources. This increases both partner and consumer confidence in the integrity of the loyalty ecosystem.

MediLink Therapeutics Taps Major Banks for Hong Kong Float
MediLink Therapeutics Taps Major Banks for Hong Kong Float

Arabian Post

time21 hours ago

  • Arabian Post

MediLink Therapeutics Taps Major Banks for Hong Kong Float

MediLink Therapeutics Ltd. is preparing to launch an initial public offering in Hong Kong, having secured China International Capital Corp., JPMorgan Chase & Co. and Morgan Stanley as its lead advisers, according to people with knowledge of the matter. The move comes as the clinical-stage biotech firm seeks to capitalise on growing investor interest in advanced tumour-targeting therapies and consolidate its platform of antibody‑drug conjugates. Founded in 2020 and headquartered in Suzhou with R&D operations in Shanghai and Boston, MediLink has developed a proprietary ADC technology known as TMALIN®. The platform facilitates precise delivery of cytotoxic agents to tumour cells, with the intention of widening therapeutic windows for solid tumour treatments. Its pipeline includes programs that have advanced to clinical stages in both China and the United States, supported by a Series B financing round of approximately USD 70 million in 2022. MediLink's strategic engagement of three underwriters reflects heightened confidence in anchor investors and broader syndication. China International Capital Corp. brings deep roots in Chinese capital markets and extensive IPO experience in the biotech sector. JPMorgan and Morgan Stanley add global banking heft and access to international investors. ADVERTISEMENT CICC itself is emerging as a top-tier sponsor for Hong Kong listings. It led or co-led 19 IPOs for Chinese corporates last year, raising USD 3.84 billion, positioning it as a dominant force amid market revival. The engagement of internationally renowned banks alongside CICC is likely aimed at boosting MediLink's valuation and widening investor interest both locally and abroad. While IPO details remain confidential, analysts suggest MediLink could seek a valuation in the mid‑to‑high hundreds of millions of dollars. That would reflect both the advanced stage of its pipeline and prevailing market multiples for ADC developers. Comparable biotech flotations in Hong Kong and the U.S. have reflected growing appetite for oncology-focused platforms. Alongside listing ambitions, MediLink continues to advance its clinical and licensing goals. In March it unveiled preclinical data at the American Association for Cancer Research annual meeting; earlier in the year it received FDA clearance for its IND application for YL217, its lead candidate. YL201, another programme, received Breakthrough Therapy Designation in January for treatment of recurrent/metastatic nasopharyngeal carcinoma. The company has also pursued strategic licensing agreements with global pharmaceutical firms to expand development and commercialisation capabilities. A licensing deal under discussion ahead of the IPO is believed aimed at enhancing distribution reach while reinforcing MediLink's balance sheet. The IPO effort is part of a broader resurgence in biotech listings in Hong Kong, where authorities have eased regulations to attract innovation-driven offerings. CICC and other banks have ramped up support for ADC and gene therapy companies, signalling a turning point after a lull in listings. ADVERTISEMENT MediLink's choice of banks aligns with a wider trend: CICC has co-sponsored blockbuster floats including the forthcoming mega‑IPO of CATL, while banks like Goldman Sachs and Morgan Stanley have also participated. In this context, MediLink is positioning itself to tap both deep domestic networks and international capital. Stakeholder sentiment appears optimistic. MediLink's management team, comprised of co‑founders Tony Xue and Jiaqiang Cai alongside C‑suite leaders experienced in drug development and financial strategy, has overseen steady progress in its ADC pipeline and established global partnerships. Jason Li's appointment as CFO in 2023 reportedly strengthened the company's capital market readiness. Market observers highlight challenges ahead. ADC development remains capital-intensive, clinical risks high, and competition fierce among domestic and international peers. Success will hinge on late‑stage data and licensing traction. At the same time, geopolitical tensions and volatility in Hong Kong equity markets may affect investor sentiment. MediLink must also navigate post‑IPO obligations, including regulatory reporting and corporate governance under Hong Kong's Main Board requirements. Mitigating execution risk will be critical, underscoring the role of its chosen bankers in underwriting diligence and market support. Analysts describe the listing as a pivotal moment: it offers the backing to fund Phase II/III efforts while elevating MediLink's corporate profile. For banks, it reinforces Hong Kong's appeal as a biotech capital market when compared with established centres like Nasdaq. With its IPO process underway, MediLink now awaits market timing and regulatory clearances before formally filing a prospectus. The company is expected to continue advancing clinical data, strengthening licensing ties, and preparing investor materials aligned with regulatory requirements.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store